Pharmaceuticals news FT.com

Merck held talks to buy Swiss biotech MoonLake for more than $3bn

US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent

Jun 2, 2025 - 23:00
 0
Merck held talks to buy Swiss biotech MoonLake for more than $3bn
US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent
Read More

Tags:

Previous Article

FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People

Next Article

Today’s D Brief: Dramatic strikes hit Russian airbases; WH’s 2026 budget; Army’s...

Related Posts

23andMe sale grafts a happy ending on to a glum tale

23andMe sale grafts a happy ending on to a glum tale

May 20, 2025  0

The cost of Trump’s attack on American science

The cost of Trump’s attack on American science

May 12, 2025  0

23andMe founder says Fortune 500 company backs new buyout offer

23andMe founder says Fortune 500 company backs new buyo...

Jun 1, 2025  0